Serum ferritin as a prognostic biomarker in CAR-T therapy for multiple myeloma: A meta-analysis

Serum ferritin as a prognostic biomarker in CAR-T therapy for multiple myeloma: A meta-analysis

Serum ferritin, a marker of systemic inflammation and iron metabolism, has been implicated in the outcomes of patients with relapsed/refractory multiple myeloma (R/R MM). However, its prognostic significance in R/R MM patients undergoing chimeric antigen receptor-modified T-cell (CAR-T) therapy rem...

Full description

Saved in:
Bibliographic Details
Main Authors: Jing Cheng, Yuan Song
Format: Article
Language:English
Published: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2025-03-01
Series:Biomolecules & Biomedicine
Subjects:
Multiple myeloma
chimeric antigen receptor-modified T cells
CAR-T
ferritin
survival
progression
Online Access:http://www.bjbms.org/ojs/index.php/bjbms/article/view/12129
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items